LATEST
Bombay Burmah share price jumps 9.5% after ₹249 crore block deal - check details✦Highlights from the art exhibition ‘Continuum ’26’✦Berlin's acute housing shortage and soaring rents dominate city election✦Turki Alalshikh announces Riyadh Season to host 2026 Ethnosport Cultural Festival✦18th Abu Dhabi World Professional Jiu-Jitsu Championship gets ready to receive 12,000 athletes✦
Fri, Sep 18, 2026
Loading weather...
Markets

Biogen Publishes EMPAVELI Data Showing Reduced Proteinuria In Adolescents With Kidney Diseases

(RTTNews) - Biogen Inc. (BIIB), a biotech company focused on developing therapies for neurological, neurodegenerative an...

By Dhallo News · September 18, 2026 at 11:31 AM IST

(RTTNews) - Biogen Inc. (BIIB), a biotech company focused on developing therapies for neurological, neurodegenerative and rare diseases, announced the publication of pre-specified adolescent subgroup data from the Phase 3 VALIANT study of EMPAVELI in Clinical Journal of the Ameri

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Bombay Burmah share price jumps 9.5% after ₹249 crore block deal - check details

Bombay Burmah Trading Corporation's shares surged nearly 10% following a large b...

Read Article »

Lodha Developers share price gains over 4% on rate hike bets - Check how other realty stocks are performing today

Lodha Developers jumped more than 4% on the BSE to ₹1,148.50 per share, making i...

Read Article »

Turkey's Regulators Act to Stem Market Rout

Turkish officials are trying to stop a meltdown at some of the country’s most pr...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.